CFGS
RPTX

Concourse Financial Group Securities’s Repare Therapeutics RPTX Stock Holding History

Concourse Financial Group Securities’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$16.4K – 2430
2021
Q1 		$15K Buy
+500
New +$17K ﹤0.01% 1656

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Concourse Financial Group Securities's RPTX Position: Q2 2021 in Review

Concourse Financial Group Securities sold out of Repare Therapeutics (RPTX) in Q2 2021, closing a stake of 500 shares — an estimated $16.4K sold.

Concourse Financial Group Securities first reported a position in RPTX in Q1 2021 and held it in 1 quarter. The position peaked at $15K in Q1 2021. 61 funds tracked by Wall St. Rank hold RPTX as of Q2 2021.

  • Concourse Financial Group Securities reported no remaining Repare Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 500 Repare Therapeutics shares in Q2 2021, an estimated $16.4K.
  • Concourse Financial Group Securities first reported a position in Repare Therapeutics in Q1 2021 and held it in 1 quarter.
  • Concourse Financial Group Securities's Repare Therapeutics position peaked at $15K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2021.

Based on Concourse Financial Group Securities's 13F filing for Q2 2021, filed 13 Aug 2021.